Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 111.20
-4.36 (-3.77%)
Jul 31, 2026, 3:00 PM CST
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 50.04 billion as of July 31, 2026. Its market cap has increased by 13.22% in one year.
Market Cap
50.04B
Enterprise Value
46.89B
Revenue
5.67B
Ranking
n/a
PE Ratio
20.74
Stock Price
111.20
ChartMarket Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 50.04B, an increase of 188.46%. That is a compound annual growth rate of 20.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 50.04B | 6.77% |
| Dec 31, 2025 | 46.87B | 73.87% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 70.90B |
| Pharmaron Beijing | 62.17B |
| Asymchem Laboratories (Tianjin) | 54.23B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.78B |
| Beijing Wantai Biological Pharmacy Enterprise | 37.24B |
| Suzhou Zelgen Biopharmaceuticals | 34.84B |
| Shanghai RAAS Blood Products | 33.95B |
| Chongqing Zhifei Biological Products | 30.23B |